Skip to main content
Fig. 2 | Journal of Nanobiotechnology

Fig. 2

From: Light triggered release of a triple action porphyrin-cisplatin conjugate evokes stronger immunogenic cell death for chemotherapy, photodynamic therapy and cancer immunotherapy

Fig. 2

The anticancer activity of NP@Pt-1. A Relative cell viability of CT26 cells with various treatments by an MTT assay. B Quantification of apoptosis rates of CT26 cells treated with different drugs. C Apoptosis rates of CT26 cells by flow cytometry. D Calcein/PI staining images of CT26 cells following different treatments. Calcein labeled live cells were shown in green fluorescence, and PI labeled dead cells were shown in red fluorescence. E Calcein/PI staining images of CT26 on 3D tumor spheroids following various treatments. (***p < 0.001)

Back to article page